A recent study published in JAMA Pediatrics on September 29 found that the HPV vaccine remains highly effective 17 years after its introduction.
According to the study, the vaccine continues to provide strong protection for young women, even for those who did not complete the full series of doses.
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, with low-risk types causing genital warts and high-risk types linked to cancers of the cervix, anus, and oropharynx.
The HPV vaccine plays a crucial role in reducing cancer risk among young women.
Author's summary: HPV vaccine remains effective 17 years after introduction.